We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
California biotech Apexigen has raised $73 million from a pair of financings that will be used for clinical testing of its lead CD40-targeting immuno-oncology candidate as well as to broaden its pipeline.
The CEO and CMO of Adverum Biotechnologies have left the gene therapy startup. Adverum said Amber Salzman, Ph.D., stepped down as CEO and president by “mutual determination,” while CMO Athena Countouriotis, M.D., resigned after less than one year in the j